The Diltiazem Extended-Release Capsu, cataloged under National Stock Number 6505-01-353-9848, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-353-9848 |
| Primary Part Number | NDC00093-5118-98 |
| Item Name | Diltiazem Extended-Release Capsu |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Therapeutic Equivalent | TO CARDIZEM-CD BY MARION MERRELL DOW |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 90.000 |
| Active Medicament Medicinal Strength | 240.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00187-0797-42 | Bausch Health, Canada Inc. (CAN) |
| NDC00093-5118-98 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| 00093511898 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00088-1797-42 | 3/9 Design control — primary reference Sanofi Us Services Inc. |
| NDC00228-2578-09 | 5/9 Secondary reference Actavis Elizabeth Llc Dba Actavis Us Div Actavis Pharma, Inc. |
| 00228257809 | 5/9 Secondary reference Actavis Elizabeth Llc Dba Actavis Us Div Actavis Pharma, Inc. |
NSN 6505-01-353-9848 is a Diltiazem Extended-Release Capsu, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-353-9848 has 3 manufacturer part numbers on file: NDC00187-0797-42 (Bausch Health, Canada Inc.), NDC00093-5118-98 (Teva Pharmaceuticals Usa, Inc.), 00093511898 (Teva Pharmaceuticals Usa, Inc.).
Key specifications for NDC00093-5118-98: Therapeutic Equivalent: TO CARDIZEM-CD BY MARION MERRELL DOW; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 90.000. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.